P

Pacific Shuanglin Bio pharmacy Co Ltd
SZSE:000403

Watchlist Manager
Pacific Shuanglin Bio pharmacy Co Ltd
SZSE:000403
Watchlist
Price: 21.45 CNY -3.77% Market Closed
Market Cap: 15.6B CNY
Have any thoughts about
Pacific Shuanglin Bio pharmacy Co Ltd?
Write Note

Relative Value

The Relative Value of one Pacific Shuanglin Bio pharmacy Co Ltd stock under the Base Case scenario is 36.84 CNY. Compared to the current market price of 21.45 CNY, Pacific Shuanglin Bio pharmacy Co Ltd is Undervalued by 42%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
36.84 CNY
Undervaluation 42%
Relative Value
Price
P
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
96
vs Industry
48
Median 3Y
7.3
Median 5Y
9.7
Industry
7.7
Forward
5.2
vs History
96
vs Industry
5
Median 3Y
32.1
Median 5Y
36.6
Industry
22.7
Forward
20.1
vs History
95
vs Industry
5
Median 3Y
30.3
Median 5Y
40.6
Industry
21.6
vs History
74
vs Industry
3
Median 3Y
45.7
Median 5Y
47
Industry
25.2
vs History
84
vs Industry
32
Median 3Y
2.4
Median 5Y
2.8
Industry
2.5
vs History
96
vs Industry
41
Median 3Y
6.9
Median 5Y
9.6
Industry
7.7
Forward
4.8
vs History
95
vs Industry
28
Median 3Y
13.7
Median 5Y
18.6
Industry
9
vs History
96
vs Industry
3
Median 3Y
30
Median 5Y
38.8
Industry
4.2
Forward
14.6
vs History
96
vs Industry
3
Median 3Y
30
Median 5Y
38.8
Industry
4.1
Forward
16.8
vs History
95
vs Industry
5
Median 3Y
28.3
Median 5Y
38.7
Industry
5.7
vs History
85
vs Industry
2
Median 3Y
96.6
Median 5Y
87.3
Industry
3.6
vs History
82
vs Industry
41
Median 3Y
2.5
Median 5Y
3
Industry
4.6

Multiples Across Competitors

Competitors Multiples
Pacific Shuanglin Bio pharmacy Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Pacific Shuanglin Bio pharmacy Co Ltd
SZSE:000403
15.7B CNY 5.5 19 15.8 15.8
FR
Pharnext SCA
OTC:PNEXF
6T USD 37 888 840.5 -180 080 -218 674.5 -216 179.2
US
Abbvie Inc
NYSE:ABBV
314.7B USD 5.7 61.9 15.4 23.7
US
Amgen Inc
NASDAQ:AMGN
157B USD 4.8 37.1 17.4 32.9
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
115.9B USD 10.9 -241.6 24 25.2
US
Gilead Sciences Inc
NASDAQ:GILD
112.2B USD 4 890.3 9.9 9.9
US
Epizyme Inc
F:EPE
94.1B EUR 1 859.4 -474.5 -516.7 -502.9
AU
CSL Ltd
ASX:CSL
133.6B AUD 5.9 32.9 20.3 25.3
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
82.6B USD 6 17.8 16.2 18
US
Seagen Inc
F:SGT
39.3B EUR 17.9 -54.9 -59 -53.2
NL
argenx SE
XBRU:ARGX
34.5B EUR 18.6 -130.6 -105.1 -76.6
P/E Multiple
Earnings Growth
CN
P
Pacific Shuanglin Bio pharmacy Co Ltd
SZSE:000403
Average P/E: 176.5
19
73%
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -180 080 N/A
US
Abbvie Inc
NYSE:ABBV
61.9
412%
US
Amgen Inc
NASDAQ:AMGN
37.1
73%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -241.6
42%
US
Gilead Sciences Inc
NASDAQ:GILD
890.3
75%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -474.5 N/A
AU
CSL Ltd
ASX:CSL
32.9
65%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.8
43%
US
S
Seagen Inc
F:SGT
Negative Multiple: -54.9 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -130.6 N/A
EV/EBITDA Multiple
EBITDA Growth
CN
P
Pacific Shuanglin Bio pharmacy Co Ltd
SZSE:000403
Average EV/EBITDA: 17
15.8
98%
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -218 674.5 N/A
US
Abbvie Inc
NYSE:ABBV
15.4
28%
US
Amgen Inc
NASDAQ:AMGN
17.4
63%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
24
38%
US
Gilead Sciences Inc
NASDAQ:GILD
9.9
12%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -516.7 N/A
AU
CSL Ltd
ASX:CSL
20.3
42%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.2
46%
US
S
Seagen Inc
F:SGT
Negative Multiple: -59 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -105.1 N/A
EV/EBIT Multiple
EBIT Growth
CN
P
Pacific Shuanglin Bio pharmacy Co Ltd
SZSE:000403
Average EV/EBIT: 21.6
15.8
77%
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -216 179.2 N/A
US
Abbvie Inc
NYSE:ABBV
23.7
88%
US
Amgen Inc
NASDAQ:AMGN
32.9
93%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
25.2
44%
US
Gilead Sciences Inc
NASDAQ:GILD
9.9
29%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -502.9 N/A
AU
CSL Ltd
ASX:CSL
25.3
55%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
18
54%
US
S
Seagen Inc
F:SGT
Negative Multiple: -53.2 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -76.6 N/A

See Also

Discover More
Back to Top